De V.A., Kochetkov A.I., Abdullaev Sh.P., Bochkov P.O., Klepikova M.V., Batyukina S.V., Mirzaev K.B., Ostroumova O.D.
On the possible relationship between polymorphic variants of the CYP2C19 gene, residual concentration and the presence of bleeding in patients who have suffered acute coronary syndrome and are receiving clopidogrel as part of dual antithrombotic therapy
|
№6 / 2024
|
N.V. Izmozherova, A.A. Popov, I.P. Antropova, L.I. Kadnikov, A.O. Polyanok, V.E. Ispavsky
Characterization of the plasminogen activator inhibitor type 1 gene (PAI-1) and its role in the development of arterial thrombosis
|
№9/10 / 2023
|
L.V. Vasilyeva (1), E.N. Bezzubtseva (1), E.F. Evstratova (1), E.V. Gosteva (1), I.B. Zubkova (2)
Clinical significance of genetic and inflammatory markers of bone metabolism in patients with chronic obstructive pulmonary disease and osteoporosis
|
№5 / 2021
|
Yu.G. Sandler (1), A.V. Polukhina (1), E.V. Vinnitskaya (1), I.G. Bakulin (2), Zh.V. Borunova (1), V.A. Keyyan (1)
PROGNOSTIC SIGNIFICANSE OF THE POLYMORPHISM OF GENES ASSOCIATED WITH THE RISK OF TYPE 2 DIABETES MELLITUS AND OBESITY, FOR THE DEVELOPMENT OF LIVER FIBROSIS AND HEPATIC STEATHOSIS IN PATIENTS WITH NON-ALCOHOLIC FAT LIVER DISEASE
|
№s5-17 / 2017
|
E.E. Starostina (1), S.V. Fastovets (1), L.M. Samokhodskaya (1), T.P. Rozina (1, 2), T.M. Ignatova (2), T.N. Krasnova (1, 2), N.A. Mukhin (1, 2)
ROLE OF ALLELIC VARIANTS OF HEMOSTASIS GENES IN THE RATE OF PROGRESSION OF FIBROSIS IN CHRONIC LIVER DISEASES
|
№20 / 2015
|
N.O. Pozdnyakov, A.L.Khokhlov
eNOS GENE POLYMORPHISM: PREVALENCE AND RELATIONSHIP WITH DISEASES
|
№13 / 2015
|